Stay updated on Pembrolizumab in Thymic Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Thymic Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Thymic Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check8 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check23 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.SummaryDifference2%
- Check30 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check37 days agoChange DetectedThe page has removed a citation regarding a study on the proliferative response of PD-1+CD8+ T cells and its prediction of response to anti-PD-1 therapy, which included an erratum reference.SummaryDifference0.5%
Stay in the know with updates to Pembrolizumab in Thymic Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Thymic Tumors Clinical Trial page.